Ward, A., Taylor, S., Punnett, G., Devaraj, R., Sankhalpara, C., Record, R., Batta, K., Byrne, J., Cargo, C., Chowdhury, O., Culligan, D., Cunningham, N., Knapper, S., Kulasekararaj, A., Narayanan, S., Raghavan, M., Sellar, R., Wiseman, D., Yorke, J. (2025). Patient experience sub-study of a randomised UK multicentre Phase 2 trial of ASTX727 versus hydroxycarbamide/best supportive care in myelodysplastic (MDS)/myeloproliferative (MPN) overlap syndromes (AMMO). Blood. https://doi.org/10.1182/blood-2025-8164